Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999–2000
- 1 April 2002
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 50 (4) , 608-616
- https://doi.org/10.1046/j.1532-5415.2002.50153.x
Abstract
To describe the experience of Ontario long-term care facilities that used oseltamivir during influenza outbreaks in 1999/2000. Case series. Ten Ontario long-term care facilities for older people and their residents. Older residents of long-term care facilities. Oseltamivir for treatment or prophylaxis during 11 influenza outbreaks in 1999/2000. Control of outbreaks; pneumonia, hospitalization, and death complicating acute influenza. All outbreaks were due to influenza A//H3N2/Sydney/05/97. One facility elected to use oseltamivir for treatment and amantadine for prophylaxis. The remaining nine facilities (10 outbreaks) recommended oseltamivir for treatment and prophylaxis (after amantadine failure in five and as primary prophylaxis in five). Use of oseltamivir was associated with termination of the outbreak in all eight evaluable outbreaks. Overall, 178/185 (96%) case-residents met the case definition of influenza and had complete data for evaluation. Of these, 63 (35%) were treated with antibiotics, 37 (21%) were diagnosed with pneumonia, 19 (11%) were hospitalized, and 16 (9%) died. Compared with residents receiving no therapy or who became ill while taking amantadine, residents who received oseltamivir within 48 hours of the onset of symptoms were less likely to be prescribed antibiotics, to be hospitalized, or to die (P <.05 for each outcome). These differences persisted and remained statistically significant when corrected for influenza immunization status. A total of 730 residents received oseltamivir prophylaxis for a median of 9 days (range 5–12). Of these, side effects were identified in 30 (4.1%), the most common being diarrhea (12 residents, 1.6%), cough (5, 0.7%), confusion (4, 0.5%) and nausea (4, 0.5%). Oseltamivir is safe and appears to be effective when used as treatment or prophylaxis to control outbreaks of influenza in older nursing home residents. J Am Geriatr Soc 50:608–616, 2002.Keywords
This publication has 24 references indexed in Scilit:
- Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with OseltamivirThe Journal of Infectious Diseases, 2001
- Inhaled Zanamivir for the Prevention of Influenza in FamiliesNew England Journal of Medicine, 2000
- Zanamivir Use During Transmission of Amantadine-Resistant Influenza A in a Nursing HomeInfection Control & Hospital Epidemiology, 2000
- Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent InfluenzaNew England Journal of Medicine, 1999
- Prolonged Shedding of Amantadine-Resistant Influenza A Viruses by Immunodeficient Patients: Detection by Polymerase Chain Reaction-Restriction AnalysisThe Journal of Infectious Diseases, 1995
- Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug useArchives of internal medicine (1960), 1995
- Vaccine use and the risk of outbreaks in a sample of nursing homes during an influenza epidemic.American Journal of Public Health, 1995
- Impact of Influenza on Mortality in Relation to Age and Underlying Disease, 1967–1989International Journal of Epidemiology, 1993
- Definitions of infection for surveillance in long-term care facilitiesPublished by Elsevier ,1991
- Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.American Journal of Public Health, 1987